Skip to content
Search

Latest Stories

Submit Guest Post

Doctors in Delhi see jump in breathing issues amid COVID-19, pollution

Top doctors in New Delhi are reporting a jump in respiratory problems among its residents, coinciding with the onset of peak pollution season in India's capital and raising concerns about complications for COVID-19 patients.

Doctors from five different Delhi hospitals told Reuters they have received twice the number of patients with respiratory illnesses such as bronchitis in the past two weeks.


Dust and smoke fill Delhi's air every winter, making breathing difficult for adults and children alike. Government data reviewed by Reuters shows that air quality this October has been worse than in the same month in 2019 and 2018.

"Pollutants have an inflammatory effect on the lungs and so does COVID-19," said Dhiren Gupta, a pulmonologist at Sir Ganga Ram Hospital in the city, which has reported more than 340,000 coronavirus cases.

There has not been any study in India to ascertain whether pollution leads to more severe complications among patients infected by the novel coronavirus. But a study by the Harvard T.H. Chan School of Public Health in the United States found that long-term exposure to fine particulate matter known as PM2.5 increased the risk of death from COVID-19.

"We are getting more number of cases with respiratory issues but we have to run COVID-19 tests on them too," said Hema Gupta Mittal, a senior paediatrician at Ram Manohar Lohia Hospital.

Delhi had a record spell of clean air earlier this year after the government imposed a strict nationwide lockdown to curb the coronavirus outbreak but air quality has deteriorated in the last two months.

In October, the air quality index (AQI) has averaged a "poor" 227 on a scale of 500, well above the "safe" limit of 60.

The index measures the concentration of pollutants finer than 2.5 microns in diameter that can reach deep into the lungs and cause deadly diseases including cancer and cardiac problems.

Delhi's Environment Minister Gopal Rai said the government was working to clear the toxic air by restricting construction and other dust-raising activities.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less